Faeth Therapeutics

Faeth Therapeutics company information, Employees & Contact Information

Explore related pages

Faeth Therapeutics email format Faeth Therapeutics management contacts

Related company profiles:

Everything needs food to survive and grow, including cancer. There is an entire dimension of human biology in metabolism that’s been too complex to leverage in the fight against cancer––until now.

Company Details

Employees
28
Address
San Francisco (But Entirely Remote!) , Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
https://www.faeththerapeutics.com/
Keywords
cancer, biotech, healthcare, digital health.
HQ
San Francisco (but entirely remote!)
Competitors
NourishedRx, Maia Oncology, Flatiron Health, SHEPHERD, Foodsmart, Ataraxis AI, Virta Health, GRAIL, Greywolf Therapeutics, Eureka Health.
Looking for a particular Faeth Therapeutics employee's phone or email?

Faeth Therapeutics Questions

News

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - Business Wire

CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer Business Wire

Faeth Therapeutics Proves Three-Pronged Approach to Cancer, Preclinically - Inside Precision Medicine

Faeth Therapeutics Proves Three-Pronged Approach to Cancer, Preclinically Inside Precision Medicine

Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer - Femtech Insider

Faeth Therapeutics Raises $25 Million, Reports Phase 2 Results in Ovarian and Endometrial Cancer Femtech Insider

Faeth Therapeutics Raises $25M in Funding - FinSMEs

Faeth Therapeutics Raises $25M in Funding FinSMEs

ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy - Business Wire

ESMO 2025: Faeth Therapeutics’ Phase 2 DICE Trial Shows 34% Reduction in Risk of Disease Progression with Oral Sapanisertib Plus Chemotherapy Business Wire

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors - Yahoo Finance

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors Yahoo Finance

How Faeth Therapeutics Brings Precision Nutrition to Women’s Cancers - Femtech Insider

How Faeth Therapeutics Brings Precision Nutrition to Women’s Cancers Femtech Insider

Faeth Therapeutics raises $47 million to advance clinical trials and feed the fight against cancer - PR Newswire

Faeth Therapeutics raises $47 million to advance clinical trials and feed the fight against cancer PR Newswire

Faeth Therapeutics’ R&D Platform Delivers First Cross-Disease Validation Beyond Oncology - Business Wire

Faeth Therapeutics’ R&D Platform Delivers First Cross-Disease Validation Beyond Oncology Business Wire

Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee - The AI Journal

Faeth Therapeutics Announces National Academy of Medicine Recognition for Co-founder Dr. Siddhartha Mukherjee The AI Journal

Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer - Pulse 2.0

Faeth Therapeutics: $25 Million Raised To Advance PIKTOR Phase 2 Trial Following 80% Response Rate In Endometrial Cancer Pulse 2.0

See the 17-slide presentation a tiny biotech used to raise $47 million for a new way of fighting cancer with nutrition - businessinsider.com

See the 17-slide presentation a tiny biotech used to raise $47 million for a new way of fighting cancer with nutrition businessinsider.com

This biotech is betting dietary changes can reshape cancer care. Even if it works, can Faeth make a profit? - statnews.com

This biotech is betting dietary changes can reshape cancer care. Even if it works, can Faeth make a profit? statnews.com

Faeth Therapeutics Announces Late-Breaking Presentation of Positive Phase 2 Data in Ovarian Cancer at ESMO 2025 - Business Wire

Faeth Therapeutics Announces Late-Breaking Presentation of Positive Phase 2 Data in Ovarian Cancer at ESMO 2025 Business Wire

Faeth Therapeutics Shows Preclinical Proof-of-Concept for Drug-Diet Combination to Treat Cancer, in Peer-Reviewed Publication - Business Wire

Faeth Therapeutics Shows Preclinical Proof-of-Concept for Drug-Diet Combination to Treat Cancer, in Peer-Reviewed Publication Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer - Business Wire

Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer Business Wire

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors - Business Wire

Faeth Therapeutics Appoints Dr. Stephen Hahn and Dr. Jayson Dallas to Board of Directors Business Wire

Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase - Business Wire

Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase Business Wire

Faeth Therapeutics closes $20M seed to turn nutrition into a pillar of cancer treatment - TechCrunch

Faeth Therapeutics closes $20M seed to turn nutrition into a pillar of cancer treatment TechCrunch

The Fifth Pillar of Cancer Care: Faeth Therapeutics Believes in Precision Nutrition to Starve Cancer - Genetic Engineering and Biotechnology News

The Fifth Pillar of Cancer Care: Faeth Therapeutics Believes in Precision Nutrition to Starve Cancer Genetic Engineering and Biotechnology News

Faeth raises $20m from Khosla, AgFunder to battle cancer with food - AgFunderNews

Faeth raises $20m from Khosla, AgFunder to battle cancer with food AgFunderNews

Why this cancer-starving startup, fresh off a $47M fundraise, is hungry for competition - San Francisco Business Times - The Business Journals

Why this cancer-starving startup, fresh off a $47M fundraise, is hungry for competition - San Francisco Business Times The Business Journals

Companies like Faeth Therapeutics

Greywolf Therapeutics logo - Similar company to Faeth Therapeutics

Greywolf Therapeutics

51
NourishedRx logo - Similar company to Faeth Therapeutics

Nourishedrx

67
Ataraxis AI logo - Similar company to Faeth Therapeutics

Ataraxis Ai

29
Maia Oncology logo - Similar company to Faeth Therapeutics

Maia Oncology

2
SHEPHERD logo - Similar company to Faeth Therapeutics

Shepherd

7
GRAIL logo - Similar company to Faeth Therapeutics

Grail

1.11K
Eureka Health logo - Similar company to Faeth Therapeutics

Eureka Health

5
Foodsmart logo - Similar company to Faeth Therapeutics

Foodsmart

632
Flatiron Health logo - Similar company to Faeth Therapeutics

Flatiron Health

1.56K
Virta Health logo - Similar company to Faeth Therapeutics

Virta Health

753

Top Faeth Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant